Aerie Pharma (AERI) – Trader Talk
-
Aerie Pharmaceuticals, Inc’s (AERI) Rhopressa is Particularly Well Positioned for Japan Entry - Analyst
-
Aerie Pharma (AERI) Climbs 15% After Announcing Positive Phase 3 Topline Results for Netarsudil Ophthalmic Solution 0.02% Clinical Trial in Japan
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to AERI Stock Lookup